Table 1.
Characteristics of subjects in the study at baseline
| Parameters | Group A (n = 41) | Group B (n = 39) | Control (n = 44) |
|---|---|---|---|
| Age (y) | 53.7 ± 14.2 | 51.7 ± 15.7 | 53.1 ± 13.2 |
| Sex (M/F) | 24/17 | 18/20 | 26/18 |
| BMI (Kg/m2) | 22.5 ± 2.4 | 22.1 ± 2.1 | 22.8 ± 1.8 |
| Dialysis duration (M) | 22.7 ± 6.5 | 22.9 ± 7.1 | 22.2 ± 7.2 |
| Number of comorbidities | |||
| Chronic glomerulonephritis | 23 | 21 | 25 |
| Diabetic nephropathy | 14 | 11 | 14 |
| Hypertensive nephropathy | 3 | 5 | 3 |
| Polycystic kidney disease | 1 | 2 | 2 |
| SBP (mmHg) | 135.6 ± 16.4 | 136.7 ± 16.6 | 136.3 ± 16.1 |
| DBP (mmHg) | 77.9± 12.7 | 79.1±11.5 | 81.3 ± 11.8 |
| Creatinine (mmol/L) | 912.4 ± 268.9 | 1013.5 ± 284. 1 | 948.6 ± 272.4 |
| BUN (mmol/L) | 23.5 ± 6.9 | 23.4 ± 6.3 | 22.7 ± 6.5 |
| Albumin (g/L) | 35.6 ± 1.4 | 34.8 ± 1.2 | 35.2 ± 1.6 |
| Hemoglobin (g/L) | 9.4 ± 3.5 | 9.1± 2.8 | 9. 5 ± 3.1 |
| Transferrin (g/L) | 48.5 ± 4.0 | 47.6 ± 5.2 | 49.2 ± 5.3 |
| Fasting blood glucose (mmol/L) | 6.6 ± 0.4 | 5.5 ± 0.7 | 6.5 ± 0.6 |